选择过敏原提取物用于多敏感过敏性鼻炎患者的免疫治疗
Elizabeth García1,2, Juan-Camilo Ardila1, Nardey Crespo3,4
1Otolaryngology & Allergology Research Groups, "Unidad Médico Quirúrgica de Otorrinolaringología (UNIMEQ-ORL)", Bogotá, Colombia.
Immunotherapy
|July 25, 2024
概括
过敏学家使用患者病史,过敏测试和物暴露来选择针对鼻炎的过敏原免疫疗法 (AIT) 提取物. 测试的特异性因过敏原而异,这表明可能需要进一步评估.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 过敏性鼻炎中的多敏感性对选择适当的过敏原免疫疗法 (AIT) 提取物提出了挑战.
- 精确的AIT提取物选择对于有效的鼻炎管理至关重要.
研究的目的:
- 评估过敏学家在为多敏感性鼻炎患者选择AIT提取物时使用的标准.
- 评估阿托皮测试在识别AIT相关过敏原的诊断性能.
主要方法:
- 进行了一项横截面研究,以确定影响AIT提取物选择的因素.
- 一个系统的文献综述评估了各种形测试的诊断准确性.
主要成果:
- 患者病史,阿托皮检测结果和物暴露是AIT提取物选择的主要因素.
- 亚托皮测试表明对 *Dermatophagoides spp. 的高灵敏度和特异性. * (>80%),对于物来说适度 (60%),对于*Blomia tropicalis*来说不确定.
- 该研究包括419名患者:84名儿童,149名青少年和186名成年人.
结论:
- 目前的诊断方法,包括阿托皮测试,可能需要精细化,以在多敏感的个体中进行最佳的AIT提取物选择.
- 进一步的研究,可能涉及非组件疗法 (NCT),可能是必要的,以提高AIT-提取物选择准确性.
相关概念视频
Allergic Reactions
27.3K
Overview
27.3K
Cross-reactivity
31.0K
Overview
31.0K
Antibody Structure
59.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.8K


